Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 29 | ICEECE2012 | Next issue

15th International & 14th European Congress of Endocrinology

Symposia

Current progress in the management of thyroid cancer

ea0029s69.1 | Current progress in the management of thyroid cancer | ICEECE2012

TSH suppression in differentiated thyroid cancer: how low should we go?

Cooper D.

Suppression of serum thyrotropin (TSH) is a cornerstone of thyroid cancer treatment, due to the tropic effects of TSH on thyroid cells. However, when deciding on the degree of TSH suppression during initial and long-term management, it is necessary to consider the aggressiveness of the cancer, as well as the potential for adverse effects induced by iatrogenic subclinical or overt hyperthyroidism. More aggressive TSH suppression is indicated in patients with high-risk disease o...